10-K Filing

VAREX IMAGING CORP CIK: 1681622 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001681622-17-000023`
Period End Date	20170930
Filing Date	20171213
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	var-20170929.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 60 Cash Flow Statement 118 Stockholders Equity 35 Comprehensive Income 27

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$400.00K	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$200.00K	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$83.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$500.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $0.4 and $0.2 at September 29, 2017 and September 30, 2016, respectively	`AccountsReceivableNetCurrent`	$122.20M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $0.4 and $0.2 at September 29, 2017 and September 30, 2016, respectively	`AccountsReceivableNetCurrent`	$163.60M	USD	Point-in-time
Inventories, net	`InventoryNet`	$234.50M	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories, net	`InventoryNet`	$197.40M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.80M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$13.90M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$495.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$359.90M	USD	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	37.63M	shares	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	37.63M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$148.30M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$108.90M	USD	Point-in-time
Goodwill	`Goodwill`	$74.70M	USD	Point-in-time
Goodwill	`Goodwill`	$241.90M	USD	Point-in-time
Intangibles assets	`IntangibleAssetsNetExcludingGoodwill`	$20.70M	USD	Point-in-time
Intangibles assets	`IntangibleAssetsNetExcludingGoodwill`	$91.30M	USD	Point-in-time
Investments in privately-held companies	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$49.30M	USD	Point-in-time
Investments in privately-held companies	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$52.30M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	-	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$5.50M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$11.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.40M	USD	Point-in-time
Total assets	`Assets`	$1.04B	USD	Point-in-time
Total assets	`Assets`	$622.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$41.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$58.90M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$23.90M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$62.40M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtCurrent`	$20.00M	USD	Point-in-time
Deferred revenues	`DeferredRevenueCurrent`	$12.00M	USD	Point-in-time
Deferred revenues	`DeferredRevenueCurrent`	$10.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$77.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$151.80M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$463.90M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$3.00M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$29.50M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$5.30M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$649.90M	USD	Point-in-time
Total liabilities	`Liabilities`	$86.10M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$10.30M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$11.20M	USD	Point-in-time
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.01 par value: 150,000 shares authorized, 37,633,747 issued and outstanding as of September 29, 2017; none issued and outstanding as of September 30, 2016	`CommonStockValue`	$400.00K	USD	Point-in-time
Net parent investment	`ParentCompanyInvestment`	$526.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$342.70M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$800.00K	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$35.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$526.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$379.00M	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and Varex stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.04B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and Varex stockholders' equity	`LiabilitiesAndStockholdersEquity`	$622.40M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$632.30M	USD	Annual
Revenues	`Revenues`	$620.10M	USD	Annual
Revenues	`Revenues`	$698.10M	USD	Annual
Cost of revenues	`CostOfRevenue`	$444.60M	USD	Annual
Cost of revenues	`CostOfRevenue`	$371.70M	USD	Annual
Cost of revenues	`CostOfRevenue`	$381.70M	USD	Annual
Gross margin	`GrossProfit`	$253.50M	USD	Annual
Gross margin	`GrossProfit`	$248.40M	USD	Annual
Gross margin	`GrossProfit`	$250.60M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$50.40M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$67.30M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$53.50M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$72.70M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$85.80M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$102.50M	USD	Annual
Total operating expenses	`OperatingExpenses`	$169.80M	USD	Annual
Total operating expenses	`OperatingExpenses`	$139.30M	USD	Annual
Total operating expenses	`OperatingExpenses`	$123.10M	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$83.70M	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$109.10M	USD	Annual
Operating earnings	`OperatingIncomeLoss`	$127.50M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$500.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$200.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$300.00K	USD	Annual
Interest expense	`InterestExpense`	$1.20M	USD	Annual
Interest expense	`InterestExpense`	$1.90M	USD	Annual
Interest expense	`InterestExpense`	$12.30M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-2.50M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$800.00K	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$3.20M	USD	Annual
Interest and other income (expenses), net	`NonoperatingIncomeExpense`	$100.00K	USD	Annual
Interest and other income (expenses), net	`NonoperatingIncomeExpense`	$-4.10M	USD	Annual
Interest and other income (expenses), net	`NonoperatingIncomeExpense`	$-8.90M	USD	Annual
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$74.80M	USD	Annual
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$105.00M	USD	Annual
Earnings before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$127.60M	USD	Annual
Taxes on earnings	`IncomeTaxExpenseBenefit`	$46.80M	USD	Annual
Taxes on earnings	`IncomeTaxExpenseBenefit`	$22.80M	USD	Annual
Taxes on earnings	`IncomeTaxExpenseBenefit`	$36.00M	USD	Annual
Net earnings	`ProfitLoss`	$69.00M	USD	Annual
Net earnings	`ProfitLoss`	$52.00M	USD	Annual
Net earnings	`ProfitLoss`	$80.80M	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$800.00K	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$500.00K	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$400.00K	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$51.60M	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$68.50M	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$80.00M	USD	Annual
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$1.37	USD	Annual
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$2.14	USD	Annual
Earnings per share, basic (in USD per share)	`EarningsPerShareBasic`	$1.83	USD	Annual
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$1.36	USD	Annual
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$2.12	USD	Annual
Earnings per share, diluted (in USD per share)	`EarningsPerShareDiluted`	$1.82	USD	Annual
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.40M	shares	Annual
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.60M	shares	Annual
Weighted average number of shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	37.40M	shares	Annual
Weighted average number of shares outstanding,diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.70M	shares	Annual
Weighted average number of shares outstanding,diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.70M	shares	Annual
Weighted average number of shares outstanding,diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.00M	shares	Annual

Cash Flow Statement 118 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$69.00M	USD	Annual
Net earnings	`ProfitLoss`	$52.00M	USD	Annual
Net earnings	`ProfitLoss`	$80.80M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$9.50M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$8.40M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$9.60M	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$1.70M	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	-	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$-100.00K	USD	Annual
Depreciation	`Depreciation`	$9.60M	USD	Annual
Depreciation	`Depreciation`	$16.90M	USD	Annual
Depreciation	`Depreciation`	$9.80M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$2.70M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.50M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$10.50M	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC`	$-800.00K	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC`	$-8.90M	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC`	$4.20M	USD	Annual
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-1.60M	USD	Annual
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.30M	USD	Annual
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$300.00K	USD	Annual
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of deferred loan costs	`AmortizationOfFinancingCosts`	$1.80M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-400.00K	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-1.80M	USD	Annual
Other, net	`OtherNoncashIncomeExpense`	$-700.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$23.10M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.60M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-19.30M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$23.50M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$4.20M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$25.90M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$900.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.70M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-300.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.30M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.90M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.90M	USD	Annual
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-7.20M	USD	Annual
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$28.10M	USD	Annual
Accrued operating liabilities and other long-term operating liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.80M	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$1.90M	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-1.60M	USD	Annual
Deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$2.70M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$85.20M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$74.60M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$74.20M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.20M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$34.30M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.90M	USD	Annual
Sale of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	-	USD	Annual
Sale of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$8.60M	USD	Annual
Sale of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	-	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$271.80M	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$67.90M	USD	Annual
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.20M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-100.00K	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$100.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-102.10M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-21.60M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-292.00M	USD	Annual
Net transfers from (to) parent	`ProceedsFromContributionsFromParent`	$35.80M	USD	Annual
Net transfers from (to) parent	`ProceedsFromContributionsFromParent`	$5.00M	USD	Annual
Net transfers from (to) parent	`ProceedsFromContributionsFromParent`	$-36.70M	USD	Annual
Distributions to Varian Medical Systems, Inc.	`PaymentsOfDistributionsToAffiliates`	$227.10M	USD	Annual
Distributions to Varian Medical Systems, Inc.	`PaymentsOfDistributionsToAffiliates`	-	USD	Annual
Distributions to Varian Medical Systems, Inc.	`PaymentsOfDistributionsToAffiliates`	-	USD	Annual
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.90M	USD	Annual
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Borrowings under credit agreements	`ProceedsFromLongTermLinesOfCredit`	$749.00M	USD	Annual
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	-	USD	Annual
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	-	USD	Annual
Repayments of borrowing under credit agreements	`RepaymentsOfLongTermLinesOfCredit`	$255.00M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.80M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$2.40M	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$1.70M	USD	Annual
Excess tax benefits from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$-100.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$11.90M	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-800.00K	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$36.70M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$263.30M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-36.80M	USD	Annual
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$900.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$100.00K	USD	Annual
Effects of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$300.00K	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$46.80M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$20.10M	USD	Annual
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.90M	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$83.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$500.00K	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$9.80M	USD	Annual
Cash paid for interest	`InterestPaid`	-	USD	Annual
Cash paid for interest	`InterestPaid`	-	USD	Annual
Cash paid for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income tax	`IncomeTaxesPaid`	$6.00M	USD	Annual
Purchases of property, plant and equipment financed through accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$4.00M	USD	Annual
Purchases of property, plant and equipment financed through accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$3.10M	USD	Annual
Purchases of property, plant and equipment financed through accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$9.00M	USD	Annual
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ReceiptofProperty`	-	USD	Annual
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ReceiptofProperty`	$15.00M	USD	Annual
Transfers of property, plant and equipment from Varian Medical Systems, Inc.	`ReceiptofProperty`	-	USD	Annual
Other non-cash transfers to Varian Medical Systems, Inc.	`NoncashTransferstoParent`	-	USD	Annual
Other non-cash transfers to Varian Medical Systems, Inc.	`NoncashTransferstoParent`	$1.60M	USD	Annual
Other non-cash transfers to Varian Medical Systems, Inc.	`NoncashTransferstoParent`	-	USD	Annual

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$359.30M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$526.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.60M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$379.00M	USD	Point-in-time
Net earnings attributable to Varex	`NetIncomeLoss`	$51.60M	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$68.50M	USD	Annual
Net earnings attributable to Varex	`NetIncomeLoss`	$80.00M	USD	Annual
Net earnings	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$80.80M	USD	Annual
Net transfers from parent	`NetTransfersFromToParent`	$27.10M	USD	Annual
Net transfers from parent	`NetTransfersFromToParent`	$-45.40M	USD	Annual
Net transfers from parent	`NetTransfersFromToParent`	$-18.40M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$800.00K	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$100.00K	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-100.00K	USD	Annual
Acquisition of MeVis Medical Solutions AG	`NoncontrollingInterestIncreaseFromBusinessCombination`	$10.20M	USD	Annual
Reclassification of non-controlling interests in MeVis Medical Solutions AG to redeemable non-controlling interests	`NoncontrollingInterestReclassificationFromNonredeemableInteresttoRedeemableInterest`	$10.40M	USD	Annual
Distribution to Varian Medical Systems	`DistributionstoParent`	$227.10M	USD	Annual
Options, exercises in period	`StockIssuedDuringPeriodSharesStockOptionsExercised`	123,000.00	shares	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.80M	USD	Annual
Value withheld on vesting of restricted stock	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.90M	USD	Annual
Other	`MinorityInterestPeriodIncreaseDecrease`	$-600.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.20M	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	-	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$600.00K	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	-	USD	Annual
Unrealized gain on defined benefit obligations, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	Annual
Unrealized gain on defined benefit obligations, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	Annual
Unrealized gain on defined benefit obligations, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	Annual
Tax impacts to APIC related to share-based award activity	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$2.40M	USD	Annual
Other	`AdjustmentsToAdditionalPaidInCapitalOther`	$-200.00K	USD	Annual
Shares outstanding, end of period	`CommonStockSharesOutstanding`	37.63M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$359.30M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$526.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$495.60M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$379.00M	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$69.00M	USD	Annual
Net earnings	`ProfitLoss`	$52.00M	USD	Annual
Net earnings	`ProfitLoss`	$80.80M	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	-	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$600.00K	USD	Annual
Unrealized gain on interest rate swap contracts, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	-	USD	Annual
Unrealized gain on defined benefit obligations, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	Annual
Unrealized gain on defined benefit obligations, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	Annual
Unrealized gain on defined benefit obligations, net of tax	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	Annual
Change in unrealized loss, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	Annual
Change in unrealized loss, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-100.00K	USD	Annual
Change in unrealized loss, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-300.00K	USD	Annual
Reclassification adjustments, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	Annual
Reclassification adjustments, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	Annual
Reclassification adjustments, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-400.00K	USD	Annual
Other comprehensive earnings (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$800.00K	USD	Annual
Other comprehensive earnings (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$100.00K	USD	Annual
Other comprehensive earnings (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-100.00K	USD	Annual
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$52.80M	USD	Annual
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$69.10M	USD	Annual
Comprehensive earnings	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$80.70M	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$400.00K	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$500.00K	USD	Annual
Less: Net earnings attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$800.00K	USD	Annual
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$68.60M	USD	Annual
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$52.40M	USD	Annual
Comprehensive earnings attributable to Varex	`ComprehensiveIncomeNetOfTax`	$79.90M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.